Top segments and regional performance

Last year, the company generated ‪184.00 M‬ EUR, the most of which — ‪184.00 M‬ EUR — came from its top-performing segment, Innovative Therapies, compared to ‪192.01 M‬ EUR the previous year. The greatest contribution came from United States, which accounted for ‪184.00 M‬ EUR last year, with ‪192.01 M‬ EUR the year before.